✦ LIBER ✦

103 Long-Term Outcome of Paediatric-Onset Crohn's Disease: A Population-Based Study

✍ Scribed by Anaïs Peneau; Julia Salleron; Mathurin Fumery; Guillaume Savoye; Eric Lerebours; Jean-Louis Dupas; Veronique Merle; Antoine Cortot; Olivier Mouterde; Claire Spyckerelle; Djamal-Dine Djeddi; Dominique Turck; Laurent Peyrin Biroulet; Jean-Frederic Colombel; Corinne Gower-Rousseau

Book ID: 119432943
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 199 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(12)60098-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P137 Long-term outcome of paediatric-ons

P137 Long-term outcome of paediatric-onset Crohn's disease: A population-based study

✍ A. Peneau; J. Salleron; M. Fumery; G. Savoye; E. Lerebours; J.-L. Dupas; V. Merl 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 55 KB

OP18 Long-term outcome after first intes

OP18 Long-term outcome after first intestinal resection in paediatric-onset Crohn's disease: A population-based study

✍ M. Boualit; J. Salleron; D. Turck; M. Fumery; G. Savoye; J.-L. Dupas; E. Lerebou 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Long-term outcome of paediatric Crohn's

Long-term outcome of paediatric Crohn's disease

✍ E. Felici; F. Torrente; A. Barabino; A. Pistorio; C. Salvestrini; R. Heuschkel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 54 KB

S2008 Long- Term Outcome of Treatment Wi

S2008 Long- Term Outcome of Treatment With Infliximab in Paediatric Crohn's Disease:a Population-Based Study

✍ Crombé, Valérie; Salleron, Julia; Savoye, Guillaume; Dupas, Jean-Louis; Vernier- 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-term outcome of treatment with infl

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

✍ Valérie Crombé; Julia Salleron; Guillaume Savoye; Jean-Louis Dupas; Gwénola Vern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Background: We examined short-and long-term benefits and safety of infliximab (IFX) in a population-based cohort of Crohn's disease (CD) patients <17 years old at diagnosis. ## Methods: The following parameters were assessed: short-and long-term efficacy of IFX, impact of drug efficacy, and mode

Long-term outcome after first intestinal

Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: A population-based study

✍ Médina Boualit; Julia Salleron; Dominique Turck; Mathurin Fumery; Guillaume Savo 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 819 KB